Table 1 Comparison of the general characteristics and biochemical parameters
From: Serum omentin-1 level in patients with benign prostatic hyperplasia
BPH (n = 40) | CG (n = 30) | p | |
|---|---|---|---|
Age (years) | 59.15 ± 7.382 | 59.07 ± 7.593 | 0.963 |
BMI (kg/m2) | 26.20 ± 3.48 | 22.56 ± 3.01 | < 0.001 |
SBP (mmHg) | 126.6 ± 10.8 | 124.5 ± 11.8 | 0.706 |
DBP (mmHg) | 76.1 ± 8.3 | 72 ± 9.2 | 0.059 |
Waist circumference (cm) | 90.33 ± 14.06 | 88.93 ± 12.89 | 0.671 |
TG (mmol/L) | 1.81 ± 0.26 | 1.71 ± 0.18 | 0.091 |
TC (mmol/L) | 4.56 ± 0.86 | 4.14 ± 1.01 | 0.073 |
HDL (mmol/L) | 1.22 ± 0.31 | 1.18 ± 0.24 | 0.561 |
Fasting glucose (mmol/L) | 4.76 ± 0.96 | 4.34 ± 0.94 | 0.076 |
BUN (mmol/L) | 5.40 ± 1.57 | 4.80 ± 1.12 | 0.084 |
eGFR (mL/min/1.73 m2) | 76.18 ± 8.37 | 79.97 ± 7.64 | 0.055 |
Creatinine (μmol/L) | 81.46 ± 17.26 | 72.92 ± 17.63 | 0.047 |
PSA (ng/mL) | 2.29 ± 0.89 | 1.72 ± 0.73 | 0.005 |
Omentin-1 (ng/mL) | 27.31 ± 4.56 | 33.47 ± 4.92 | < 0.001 |
Prostate volume (mL) | 62.00 ± 30.26 | 10.64 ± 1.29 | < 0.001 |